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Abstract Multiple chemical sensitivity (MCS) patients
usually react to odour compounds and the majority of
neuroimaging studies assessed, especially at the cortical
level, many olfactory-related correlates. The purpose of the
present study was to depict sub-cortical metabolic changes
during a neutral (NC) and pure (OC) olfactory stimulation
by using a recently validated 18F-2-fluoro-2-deoxy-D-glu-
cose (FDG)-positron emission tomography/computer
tomography procedure in 26 MCS and 11 healthy (HC)
resting subjects undergoing a battery of clinical tests.
Twelve subcortical volumes of interest were identified by
the automated anatomical labeling library and normalized
to thalamus FDG uptake. In both groups, when comparing
OC to NC, the within-subjects ANOVA demonstrated a
relative decreased metabolism in bilateral putamen and
hippocampus and a relative increased metabolism in
bilateral amygdala, olfactory cortex (OLF), caudate and
pallidum. The between-groups ANOVA demonstrated in
MCS a significant higher metabolism in bilateral OLF
during NC. As in HC subjects negative correlations were
found in OC between FDG uptake in bilateral amygdala
and hippocampus and odor pleasantness scale, the latter
positively correlated with MCS subjects’ bilateral putamen
FDG uptake in OC. Besides FDG uptake resemblances in
both groups were found, for the first time a relative higher
metabolism increase in OLF in MCS subjects at rest with
respect to HC was found. When merging this aspect to the
different subcortical FDG uptake correlations patterns in
the two groups, the present study demonstrated to describe
a peculiar metabolic index of behavioral and neurological
aspects of MCS complaints.
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Introduction
Multiple chemical sensitivity (MCS)/idiopathic environ-
mental illness (IEI) is a relatively common clinical diag-
nosis in western populations (Alessandrini et al. 2013a).
The prevalence of self-reported chemical sensitivity
symptoms in population based studies ranges from 9 to
33 % (Dantoft et al. 2014), whereas physician diagnosed
MCS or reports of disabling consequences in the form of
social and occupational disruptions are much lower, rang-
ing from 0.5 to 6.3 % (Dantoft et al. 2014).
MCS patients usually react to a wide range of everyday
chemical compounds, such as petrol, perfume or pesticides
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(Das-Munshi et al. 2006) by complaining of a wide spec-
trum of symptoms ranging form headache, fatigue, respi-
ratory symptoms, dizziness, nausea and, especially,
dysosmia (Alessandrini et al. 2013a; Ka¨rnekull et al. 2011).
Major criteria to define the clinical spectrum of MCS
were introduced by Cullen (1987); however, the discussion
on definition and nomenclature reflects the fact that the
aetiology of MCS is still unclear and a matter of debate
(Das-Munshi et al. 2007; Alessandrini et al. 2013a). Most
frequently discussed etiologies include neurogenic inflam-
mation (Bascom et al. 1997), classical conditioning (Win-
ters et al. 2003) and biochemical disruptions (Pall 2003).
According to the neural sensitization theory, MCS is
attributed to a pathological hyper-reactivity of neurons in
olfactory and limbic areas of the brain (Bell et al. 1992).
Other MCS theories have also suggested hyper-reactivity in
the central nervous system (CNS) as an important aspect
(Bascom et al. 1997). The altered CNS responses are
hypothesized to be paralleled by increased anxiety,
avoidance, anticipatory stress (Bell et al. 1992) and atten-
tion bias (Bascom et al. 1997) to chemical exposure.
However, it remains unclear which degree of MCS smell
perception is dependent on sniffing behaviors and/or
attentional mechanism (Siegel and Kreutzer 1997).
A recent investigation reporting 18F-2-fluoro-2-deoxy-D-
glucose (FDG)-positron emission tomography (PET)/com-
puter tomography (CT) cortical changes after a pure olfac-
tory stimulation in MCS patients (Chiaravalloti et al. 2015)
demonstrated to overcome that possible unintended sensory
stimulation (Alessandrini et al. 2014a; Benjamin et al. 2010;
Hillert et al. 2007; Orriols et al. 2009, Azuma et al. 2013;
Andersson et al. 2014) related to such neuroimaging tech-
niques coupling the olfactory taskwith the acquisition phase.
These aspects could have constituted a possible common
bias to the interpretation of the majority of existing data.
Thus, it remains unclear to what extent discrepancies in the
results of different studies may reflect unwanted attentional
behaviors, sensory-specific engagement of different brain
regions rather than methodological discrepancies (Alessan-
drini et al. 2014a).
Besides, the majority of existing studies pointed at
assessing only those correlates of olfactory-related changes
that could underpin—at cortical level—MCS patients
complaints. Due to the fact that primary olfactory areas in
the brain exist outside the cerebral cortex and the neural
pathways that subserve olfactory processes are strictly
related to olfactory-limbic areas (Yeshurun and Sobel
2010), studies in this field could be useful to unravel pos-
sible interferences involving peculiar neural olfactory (and
related hedonic) pathways before reaching cortical level.
The aim of the present study was to assess the sub-cortical
metabolic changes related to a pure olfactory stimulation in
resting MCS and healthy (HC) subjects by using a recently
validated FDG-PET/CT technique (Alessandrini et al.
2014a; Chiaravalloti et al. 2015) with the purpose of
depicting the neural patterns peculiar of MCS.
Subjects and Methods
Participants and Study Design
We included in the study MCS patients admitted to the
Regional Center for Diagnosis, Prevention and Treatment
of MCS and evaluated at ‘‘Tor Vergata’’ University for
those symptoms related to ear–nose–throat complaints.
Diagnosis of MCS was achieved according to the US
Consensus Criteria for MCS (Anonymous 1999) and the
revisions suggested by Lacour et al. (2005) which were
operationalized as follows: (1) symptoms are present for at
least 6 months; (2) symptoms occur in response to expo-
sure to at least two of 11 common volatile chemicals; (3)
co-occurrence of at least one symptom from the CNS and
one symptom from another organ system; (4) symptoms
cause significant lifestyle changes, (5) symptoms occur
when exposed and lessen or resolve when the symptom-
triggering agent is removed; (6) symptoms triggered by
exposure levels do not induce symptoms in other individ-
uals who are exposed to the same levels.
We also enrolled as control group a population of gen-
der- and age-matched healthy subjects,
Both eligible MCS patients and HC were required to
meet the following entry criteria: subjects with diabetes,
oncologic or HIV history, neurological and psychiatric or
mood disorders, history of surgery, radiation and trauma to
the brain were excluded from the study. No patient showed
liver or renal abnormalities nor was pregnant or breast-
feeding. The peripheral blood of MCS and HC was tested
for the usual parameters. A detailed case history was col-
lected for all subjects who underwent ear–nose–throat
examination with fiberoptic check of the upper airways.
Neurological diseases were excluded with the mini mental
state examination and magnetic resonance imaging (MRI).
All those conditions that could potentially develop an
olfactory dysfunction were considered as exclusion criteria.
Thus, patients with sino-nasal disorders or surgery history,
head trauma, neuro-psychiatric disorders (Parkinson’s dis-
ease, Alzheimer’s disease, schizophrenia, multiple sclero-
sis and depression), lower airways and/or lung diseases,
active hepatitis, cirrhosis, chronic renal failure, Vitamin
B12 deficiency, alcohol, tobacco or drug abuse, cerebral
vascular accidents, insulin dependent diabetes mellitus,
hypothyroidism and Cushing syndrome were not included
in the study. Finally, we excluded all subjects taking drugs
possibly impacting on FDG uptake and distribution in the
brain (Varrone et al. 2009).
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The Ethics Committee of ‘‘Tor Vergata’’ University
School of Medicine approved the protocol research. The
study adhered to the principles of the Declaration of Hel-
sinki and all of the participants provided written informed
consent after receiving a detailed explanation of the study.
Experimental Procedure
According to previous studies of this research group
(Alessandrini et al. 2014a; Chiaravalloti et al. 2015), all
subjects underwent FDG-PET/CT after both a neutral
(neutral condition—NC) and pure olfactory stimulation
(olfactory condition—OC) by using a ordinary aerosol
facial mask containing in its ampoule: only 5 ml of saline
sodium chloride (NaCl) 0.9 % in NC and a solution of
1.5 ml of Vanilline 100 % (Dacor Ltd|Sarandrea Ltd) and
5 ml NaCl 0.9 % in OC.
In order to avoid a close radiation exposure and possible
expectations related to the presence of an odor, same indi-
viduals underwent the second procedure after 1 month by
using a computer-generated randomization schedule. Under
both conditions the oxygen flow rate was 3.5 l/min. Before
the stimulation period each patient lay for 30 min with the
eyes closed in a semidarkened and quiet room without any
artificial stimulation. Taking into account the kinetics of
FDG in the brain and the fact that during olfactory experi-
ments subjects may automatically control their olfactory
exposure by altering their respiration and attention to
olfaction during the task condition (Savic 2002; Chiaraval-
loti et al. 2015), FDG was injected after 3 min of a contin-
uous 9-min block stimulation with instructions not to sniff
but only inhale the supplied air constantly. The duration of
the brain PET acquisitionwas 15 min andwas started 24 min
from the end of the olfactory stimulation in all the patients.
PET/CT Scanning
The PET/CT system Discovery ST16 (GE Medical Sys-
tems, TN, USA) was used for the whole population in
study. This system combines a high-speed ultra 16-detec-
tor-row (912 detectors per row) CT unit and a PET scanner
with 10,080 bismuth germanate (BGO) crystals in 24 rings
with a 128 9 128 matrix. Before and after the FDG
injection, hydratation (500 ml of i.v. NaCl) 0.9 %) was
performed in order to reduce the pooling of the radiotracer
in the kidneys. All subjects had normal serum glucose level
and fasted for at least 5 h before the 18F-FDG injection.
Olfactory Assessment and Validated Questionnaires
(VQ)
Olfactory performance was assessed in both groups at the
time of enrollment with the multiple-forced choice Sniffin’
Sticks Screeinng test (SST; Kobal et al. 1996) in four main
domains: odor threshold (OT), odor discrimination (OD),
odor identification (OI) and their sum (TDI).
Moreover, all subjects completed the following VQ:
• Questionnaire of Olfactory Disorders (QOD)—com-
pleted only before NC phase—to assess daily life
problems due to olfactory impairment. A short modified
version of an olfactory-specific QOD developed by
Frasnelli and Hummel (Simopoulos et al. 2012) was
used. This version consists of 25 statements divided
into three general domains: 17 negative (QOD-NS),
two positive (QOD-PS), and six socially desired
statements (QOD-SD);
• Zung Self-Rating Anxiety Scale (SAS)—completed
only before NC phase—is a 20-item scale with some of
the items keyed positively and some negatively on a
four-point scale ranging from 1 (none or a little of the
time) to 4 (most or all of the time). The final score
ranges from 20 to 80, a score between 20 and 44 is
considered in the normality range, 45–59 reflects mild
to moderate anxiety, 60–74 severe and 75–80 very
severe anxiety (Zung and Gianturco 1971);
• Intensity Visuo-Analogue Scale (IVAS), in which each
subject may score from 0 to 10 the subjective intensity
of olfactory perception (Lombion-Pouthier et al. 2006)
after both NC and OC;
• Pleasantness Visuo-Analogue Scale (PLEAS), in which
each subject may score from 0 to 10 the subjective
pleasantness of olfactory perception (Lombion-Pouthier
et al. 2006) after the OC.
Statistical Analysis
Differences were analyzed by segmenting sub-cortical
regions and comparing 18F-FDG uptake between NC and
OC. Anatomical automatic labeling (AAL; Tzourio-Ma-
zoyer et al. 2002) structural VOIs were downloaded from
the MarsBaR project download page (http://sourceforge.
net/projects/marsbar/) and converted from MarsBaR to
nifti format by an in-house modified version of the Mars-
BaR function mars_roi-s2img.m. The dataset to be ana-
lyzed was obtained by an in-house created Matlab-based
script that automatically processed mean FDG uptake sig-
nal intensities within VOIs and stored them into a matrix in
which all values were intra-individually normalized to
those of the reference VOI (Pagani et al. 2014). All these
calculations were performed by the script in a single step
allowing a substantial spare of time and rendering friendly
and simple the whole process. The mean FDG uptake
values in each of the 12 chosen sub-cortical VOIs (bilateral
amygdala, caudate, olfactory, pallidum, putamen and hip-
pocampus) were computed at both NC and OC. Data for
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each VOI were normalized to the uptake mean of thalami.
The choice of thalami as normalizing factor was based on
the findings of previous studies in which this region with
high gray matter density unlike i.e. cerebellum (Chiar-
avalloti et al. 2015; Alessandrini et al. 2013b, 2014b) was
not found to be affected by MCS.
Statistical differences were calculated by means of a
‘between-groups’ and ‘within-subjects’ analysis of variance
(ANOVA). Further, a between-subject ANOVA was per-
formed for all VQ and SST scores, at NC and OC. Age and
sex were treated as continuous and categorical predictors,
respectively. Bonferroni correction for multiple compar-
isons was used to test post hoc of significant main effects.
Significant cut-off level (a) was set at a P value of 0.01.
In order to assess that data were of Gaussian distribu-
tion, D’Agostino K2 normality test has been applied (where
the null hypothesis is that the data are normally dis-
tributed). Then Spearman’s rank correlation was performed
between significant values of subcortical VOIs mean
intensity, SST and VQ scores recorded at NC and OC and a
Bonferroni correction for multiple comparisons has been
applied (STATISTICA 7 package for Windows).
Results
Subjects
Thirty-one consecutive MCS patients were enrolled.
Among them, three were using antidepressant drugs, one
reported history of alcohol abuse, one of hypothyroidism
and were excluded.
Therefore, 26 MCS patients (20 women and 6 men, mean
age 46.7 ± 11 years) met the eligible criteria and were
included in the study. The control group (HC) consisted of 11
right-handed healthy individuals (six women and five men;
mean age 45.7 ± 11 years). Table 1 depicts main sociode-
mographic variables of HC and MCS subjects.
PET/CT Data
In both MCS and HC subjects a relative decreased meta-
bolism (P\ 0.01) in bilateral putamen and hippocampus
was found at OC as compared to NC. Conversely, a relative
increased metabolism (P\ 0.01) in bilateral amygdala,
caudate, pallidum and olfactory cortex (OLF)—including
olfactory tubercle, anterior olfactory nucleus, piriform
cortex, anterior cortical nucleus of the amygdala, peri-
amygdaloid cortex, and entorhinal cortex (De´jerine 1980;
Sakamoto et al. 1999; Tzourio-Mazoyer et al. 2002)—was
found in OC as compared to NC (Tables 2, 3; Fig. 1).
Table 1 General overview of
the population examined,
including sociodemographic
variables
Male (±SD) Female (±SD) P value
MCS
Age 45.6 (±9) 47.6 (±12) F = 0.88; P = 1
Education: BUL 4 13 P = 1
Education: ULoA 2 7
Occupation: M 0 3 P = 1
Occupation: S 6 18
HC
Age 45.5 (±10) 48.2 (±8) F = 0.84; P = 1
Education: BUL 5 3 P = 0.54
Education: ULoA 1 3
Occupation: M 3 2 P = 1
Occupation: S 3 4
BUL below university level, ULoA university level or above, M manual, S skilled
Table 2 Neutral (NC) and olfactory (OC) details of the FDG uptake
(means and standard deviations, SDs) in each significant (P\ 0.01)
VOI normalized to the uptake mean of thalami in MCS subjects
VOIs NC normalized
uptake (means
and SDs)
OC normalized
uptake (means
and SDs)
Left amygdala 0.77 ± 0.03 0.87 ± 0.06
Right amygdala 0.76 ± 0.04 0.87 ± 0.03
Left caudate 0.78 ± 0.06 1.13 ± 0.07
Right caudate 0.78 ± 0.05 1.12 ± 0.05
Left olfactory cortex 0.78 ± 0.04 1.11 ± 0.05
Right olfactory cortex 0.77 ± 0.04 1.10 ± 0.06
Left pallidum 0.87 ± 0.03 1.12 ± 0.04
Right pallidum 0.86 ± 0.04 1.11 ± 0.05
Left putamen 0.89 ± 0.04 0.77 ± 0.05
Right putamen 0.88 ± 0.05 0.76 ± 0.06
Left hippocampus 0.93 ± 0.03 0.75 ± 0.06
Right hippocampus 0.92 ± 0.04 0.74 ± 0.04
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Further, the between-groups ANOVA with multiple
comparisons correction demonstrated that MCS individuals
had a significant higher metabolism (P\ 0.05) in bilateral
OLF during NC, as compared to HC (Fig. 2).
Olfactory Assessment and Validated Questionnaires
(VQ)
A significant statistical increase in QOD NS, SAS, OT,
TDI and IVAS OC scores was found in MCS as compared
to HC subjects. Conversely, a significant statistical increase
in PLEAS scores was found in HC as compared to MCS
subjects (detailed means and standard deviations are shown
in Table 4).
Correlation Analysis
In HC subjects negative correlations were found in OC
between PLEAS scores and FDG uptake in left (Fig. 3a)
and right (Fig. 3b) amygdala (r = -0.60 and -0.70,
respectively, P\ 0.01) and left (Fig. 3c) and right
(Fig. 3d) hippocampus (r = -0.68 and -0.65, respec-
tively, P\ 0.01).
In MCS subjects Spearman’s rank order correlations
proved in OC a significant positive correlation between left
(Fig. 3e) and right (Fig. 3f) putamen FDG uptake and
PLEAS scores (r = 0.48 and 0.47, respectively, P\ 0.01).
Discussion
The first interesting finding of the present study is the
significant (P\ 0.05) relative higher FDG uptake during
NC in MCS OLF with respect to HC (Fig. 2). Beside a
relative paucity of information about etiopathological
underpinning and olfactory-related brain responses of in
MCS, diverse theories have been proposed in previous
indexed studies (Andersson et al. 2014; Hillert et al. 2007;
Azuma et al. 2013; Chiaravalloti et al. 2015; Orriols et al.
2009).
The relative FDG uptake increase found in the present
study in MCS patients OLF at rest when compared to HC is
in line with those theories assessing CNS hypereactivity
and limbic kindling as key nodes in pathophysiological
underpinnings of MCS (Bascom et al. 1997; Winder 2002).
Agreeing with those arguments suggesting both attention
bias and over-ridden neural behaviour to chemical expo-
sure in MCS patients (Andersson et al. 2009; Wittho¨ft et al.
2006; Winder 2002), this finding could depict for the first
time a subcortical resting state correlate of hyper-sensitized
Table 3 Neutral (NC) and olfactory (OC) details of the FDG uptake
(means and standard deviations, SDs) in each significant (P\ 0.01)
VOI normalized to the uptake mean of thalami in HC subjects
VOIs NC normalized
uptake (means
and SDs)
OC normalized
uptake (means
and SDs)
Left amygdala 0.79 ± 0.05 0.86 ± 0.05
Right amygdala 0.77 ± 0.05 0.86 ± 0.05
Left caudate 0.81 ± 0.05 1.14 ± 0.04
Right caudate 0.80 ± 0.04 1.13 ± 0.04
Left olfactory cortex 0.76 ± 0.06 1.11 ± 0.05
Right olfactory cortex 0.74 ± 0.06 1.11 ± 0.05
Left pallidum 0.87 ± 0.03 1.14 ± 0.02
Right pallidum 0.86 ± 0.04 1.13 ± 0.05
Left putamen 0.90 ± 0.06 0.79 ± 0.06
Right putamen 0.89 ± 0.06 0.78 ± 0.06
Left hippocampus 0.94 ± 0.05 0.76 ± 0.05
Right hippocampus 0.94 ± 0.05 0.75 ± 0.05
Fig. 1 3D rendering showing in
green and red colour the VOIs
(with exception of olfactory
cortex) in which FDG uptake
was significantly lower and
higher, respectively, at OC as
compared to NC in both MCS
and HC subjects. Details of the
FDG uptake means and standard
deviations in each VOIs are
presented for MCS and HC in
Tables 1 and 2, respectively
(Color figure online)
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neural structure before reaching those secondary/associa-
tive olfactory ones (such as OFC, PHG) in which emo-
tional/affective/over-attentional processes could be
residing (Qureshy et al. 2000; Kroupi et al. 2012; Keller
2011) and secondary MCS disease-related processes could
be nestled (Hillert et al. 2007; Orriols et al. 2009; Hillert
et al. 2013).
Further, these data appear more relevant especially
when merged with the wider FDG uptake found at rest in
frontal–prefrontal cortex and ACC in the same sample of
HC subjects with respect to the same sample of MCS
patients (Chiaravalloti et al. 2015). In particular we could
hypothesize the found relative hyperactivation in primary
olfactory structures (not counterbalanced by the same HC
cortical activity and the same ability in controlling the
arousing stimuli) as neural—especially olfactory—be-
havioural changes related to low-level chemical exposures
before emerging at mind level (Winder 2002).
Secondly, a relative decreased metabolism in bilateral
putamen and hippocampus and a relative increased meta-
bolism in bilateral caudate, pallidum, amygdala and OLF in
OC as compared to NC in both MCS and HC subjects were
found (Tables 2, 3; Fig. 1).
Fig. 2 Sagittal (on the top-
right), transverse (on the
bottom-left) and frontal (on the
top-left) view of significant
higher metabolism (in red
colour) in bilateral olfactory
cortex (Olf) during NC in MCS
subjects as compared to HC. On
the bottom-right, the diagram of
the FDG uptake mean and
standard deviations in MCS (red
colour) and HC (blue colour)
subjects showing the between-
group approach and significant
effect in bilateral Olf. Amy
amygdala, Cau caudate, Pall
pallidum, Put putamen, Hyp
hippocampus, L left, R right
(Color figure online)
Table 4 MCS and HC subjects’ means and standard deviations (SD)
in validated questionnaires (VQ) scores
VQ MCS HC
Mean SD Mean SD
QOD NS 21.07 1.89 0.18 0.4
QOD PS 5.26 0.72 5.36 0.67
QOD SD 15.96 1.31 16.27 1.27
SAS 45.23 6.85 21.54 3.85
OT 14.07 0.41 9.27 1.13
OD 14.03 0.72 13.81 0.87
OI 13.92 0.84 13.09 1.13
TDI 42.03 1.42 36.18 1.87
IVAS NC 0.19 0.4 0.09 0.3
IVAS OC 9.23 0.63 6.36 0.83
PLEAS 5.85 0.85 8.77 0.71
Questionnaire of Olfactory Disorders (QOD); negative (QOD-NS),
positive (QOD-PS) and socially desired statements (QOD-SD); Zung
Self-Rating Anxiety Scale (SAS); Intensity Visuo-Analogue Scale
(IVAS) during neutral (NC) and olfactory (OC) condition; Pleasant-
ness Visuo-Analogue Scale (PLEAS); Odor Threshold (OT); Odor
Discrimination (OD); Odor Identification (OI) and the sum of OT, OD
and OI (TDI). In bold character significant statistical differences
(P\ 0.01) between groups
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This network identified analyzing FDG-PET/CT data by
the AAL atlas template (Tzourio-Mazoyer et al. 2002) is
known to be in large part the primary target of olfactory
bottom-up inflow, and our results are in accordance with
previous functional and lesional neuroimaging olfactory
studies (Hillert et al. 2007; Gottfried 2006; Bitter et al.
2010) depicting the olfactory pathways as fairly distinct
from other senses’ anatomical organization.
As previously reported (Alessandrini et al. 2014a;
Chiaravalloti et al. 2015), the improved sensitivity of the
state-of-the-art PET camera allowed to explore olfactory
neural underpinnings in a defined ecologic condition,
possibly avoiding cortical activation related to unwanted
attentional processes and odor sensitivity enhancement
(A˚hs et al. 2013). Upon the present experimental condi-
tions PET studies might be considered the same way as a
functional MRI (fMRI) study in which the temporal reso-
lution is in the range of minutes instead of seconds
(Scarmeas et al. 2004).
During OC metabolic changes relate mainly to the
administered olfactory stimulus and the difference with NC
condition can be inferred by regional metabolism intensi-
ties differences.
Thus, the relative OC-related FDG uptake increase
found in MCS and HC in amygdala, pallidum, OLF and
caudate might represent a peculiar subcortical network
related to the pure olfactory condition. As OLF (and its
sub-regions including olfactory tubercle, anterior olfactory
nucleus, piriform cortex, anterior cortical nucleus of the
amygdala, periamygdaloid cortex, and entorhinal cortex
[De´jerine 1980; Sakamoto et al. 1999; Tzourio-Mazoyer
et al. 2002]) OC-related FDG uptake increase in both
Fig. 3 Diagrams showing HC and MCS correlations analysis (in
green and lilac colour, respectively) between VOIs FDG uptake and
PLEAS scores during OC: negative correlation between PLEAS
scores and FDG uptake in left (a) and right (b) amygdala (yellow
colour) and left (c) and right (d) hippocampus (in yellow colour);
positive correlation between left (e) and right (f) putamen (in yellow
colour) FDG uptake and PLEAS scores (Color figure online)
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groups is consistent with many previous pure olfactory
studies in healthy and MCS subjects (i.e. Wang et al. 2005;
Hillert et al. 2007), amygdala involvement seems to be
coherent with its peculiar role in encoding odorant stimuli
(Nigri et al. 2013) and with its engagement in the reward-
emotion network (Tomasi and Volkow 2011). Furthermore,
the OC-related caudate and pallidum relative FDG uptake
increase reflects the general trend in literature for which
they are thought to be encompassed in the task-positive
network which is involved in cognitive control during task
performance (Dosenbach et al. 2007), playing an important
role in attention (Corbetta and Shulman 2002), alertness
(Cavanna 2007), externally driven cognition, and working
memory (Corbetta and Shulman 2002).
In line withMagistretti’s observations (2006)—for which
the notion of baseline implies that during a particular task not
only activation is observed but also deactivation in certain
areas resembling the organized default mode network
(Raichle et al. 2001)—here we found both in MCS and HC a
peculiar putaminal and hippocampal relative decreased FDG
uptake during OC as compared to NC. Interestingly, previ-
ous elegant works (De Luca et al. 2006; Vincent et al. 2008)
assessed these structures as encompassed in task negative
network related to patterns described as ‘‘deactivated’’
during active tasks in PET cerebral blood flow studies
(Shulman et al. 1997; Mazoyer et al. 2001).
However, discrepancies at cortical and subcortical level
are present between this study and previous ones (i.e.
hyperactivation under odorant stimulation in prefrontal
cortex [Azuma et al. 2013]), cuneus–precuneus and ACC
[Hillert et al. 2007]). These inconsistences might derive
from diverse technical strategies in olfactory stimulation
(i.e. odours delivery, odour compounds), neuroimaging
techniques and patients enrollment procedures.
VQ Between-Groups Differences and Correlation
Analysis
MCS subjects demonstrated a pattern of responses among
VQ that is generally in accordance with the literature
(Alessandrini et al. 2013a) and resulted, when compared to
HC, in scoring significantly higher VAS OC, lower PLEAS
OC, and to be more affected by anxiety and worsened by
olfactory-related quality of life (Table 4).
Furthermore, a global increase in SST scoring was
demonstrated. However, despite this test might not be
properly suited for MCS dysosmia symptoms, it represents
the more reliable forced-choice olfactory instrument
developed to cluster subjects among their olfactory per-
formance (Kobal et al. 1996).
Moreover, when performing correlation analysis
between VQ scores and FDG uptake in both groups it was
possible to highlight two distinct patterns. In MCS a
positive correlation was found during OC between FDG
uptake in bilateral putamen and PLEAS (Fig. 3e, f). Con-
versely, in HC a negative correlation was found during OC
between FDG uptake in both bilateral amygdala and hip-
pocampus and PLEAS (Fig. 3a–d).
In line with the knowledge postulating amygdala and
hippocampus sending dense projections to the olfactory
bulb (Carmichael et al. 1994) (supplying numerous physi-
ological routes for modulation of olfactory information
processing [Gottfried 2006]) the present study showed a
sort of relative competing influences during OC in HC
subjects among amygdala and hippocampus on PLEAS.
Besides emotional experience of odor coding results of
activation along independent dimensions of intensity and
valence (Anderson et al. 2003; Gottfried 2006) amygdala
and hippocampus were pointed as key nodes in olfactory-
related coding neural stream (i.e. activity in the first
structure was previously associated to unpleasant odour
compounds [Hudry et al. 2003]) and these regions are
thought to be involved in the process of odor-elicited
emotion and odor-associated emotional memory (Kadohisa
2013). However, uncertainty in literature did not provide a
definitive association of each dimension with a relative
brain structure and under the present study conditions their
reverse metabolic behavior and relative correlations could
depict a neurobiological and psychological pattern distin-
guishing the HC olfactory-related behavior.
In turn, the peculiar positive correlation in MCS patients
during OC between FDG uptake in bilateral putamen and
PLEAS could represent a possible retuning of the physio-
logical modulation of olfactory information processing.
This aspect could be best grounded when taking into
account (i) recent fMRI studies in which the putamen was
highlighted as an important structure for stimulus–action
coding (Haruno and Kawato 2006) and (ii) previous
olfactory SPECT studies in which chemical challenge
responses in MCS individuals have been suggested to be
related more to their expectations and prior beliefs than to
the chemical itself (Das-Munshi et al. 2006).
According to those inferences previously outlined by
Carpenter (2003), differences in correlations between odor
valence scoring and diverse sub-cortical regions between
MCS and HC subjects could point attention on possible
neuropathological underpinning of MCS, suggesting a
repository of the same olfactory-related function as shifted
and hosted in diverse regions.
Conclusion
As compared to previous MCS neuroimaging studies the
reliability of the present findings are strengthened by the
robust sample of recruited subjects and by the strict MCS
250 Brain Topogr (2016) 29:243–252
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patients diagnosis. Moreover, for the first time a relative
higher metabolism increase in OLF in MCS subjects with
respect to HC was found during resting state. In turn, a
different subcortical FDG uptake correlation with odor
valence processing was depicted in the two groups.
Even though further investigations in this field are
needed, we believe this study to be useful in describing a
peculiar metabolic index of behavioral and neurological
aspects of MCS/IEI complaints.
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